浙江東日(600113.SH):終止發行A股可轉債
格隆匯3月12日丨浙江東日(600113.SH)公佈,公司於2023年3月12日召開第九屆董事會第十三次會議和第九屆監事會第八次會議,審議通過了《關於終止公司公開發行A股可轉換公司債券事項的議案》,同意終止公司公開發行A股可轉換公司債券事項的事項。
自公司公開發行A股可轉換公司債券方案公佈以來,公司董事會、經營管理層與中介機構一直積極有序推進各項相關工作,綜合考慮目前資本市場環境的變化,結合公司實際情況、發展規劃等諸多因素,公司計劃調整融資方式,經審慎分析並與中介機構等反覆討論,公司決定終止公開發行A股可轉換公司債券事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.